Stay up-to-date with our latest news, blog articles, videos, and event announcements. Learn from business success stories and gain access to valuable e-books and resources.
In small-molecule development, risk rarely appears as a single obvious event. It usually emerges through an atypical analytical result that cannot be defended, a stability trend that forces reformulation, a tech transfer that loses process intent, or an HPAPI handling gap that […]
Optimizing fill–finish for biologics begins at a point where resources are constrained, knowledge is incomplete, and regulatory scrutiny is intense. The central task is to convert a promising molecule into a phase-appropriate, manufacturable dosage form that is safe, stable, and clinically usable—often […]
In the high-stakes world of small-molecule development, the transition from pre-clinical “garage-style” synthesis to a scalable, GMP-ready clinical candidate is where most asset valuations either soar or plummet. For small and mid-sized pharma companies, this is not just a technical hurdle, it is a […]
It has been three years since our Kawagoe site became part of the Adragos family, and it is a milestone that fills me and our entire team with immense pride. This journey has been one of transformation, growth, and partnership. […]
Adragos Pharma is pleased to announce its participation in DCAT Week 2026, taking place in New York City from March 23-26th. As a global Contract Development and Manufacturing Organization (CDMO), we look forward to engaging with industry leaders, partners, and […]
In the highly regulated world of pharmaceutical manufacturing, the production of controlled substances represents a pinnacle of complexity. The process demands that requirements for quality, safety, operability, regulatory compliance, and security are all satisfied simultaneously. This unyielding standard necessitates an […]
Get notified on our latest news.
